Skip to content
Link copied to clipboard
Link copied to clipboard

Malvern pharmaceutical company ordered to pay more than $1.5 billion after admitting it mislead doctors about a powerful opioid

Endo says it will actually pay far less than the ordered payouts, which make up the second-highest financial penalty ever brought against a pharmaceutical company.

Drug manufacturer Endo, whose U.S. headquarters is in Malvern, has been ordered to pay more than $1 billion in fines and other penalties over its marketing of the opioid painkiller Opana ER.
Drug manufacturer Endo, whose U.S. headquarters is in Malvern, has been ordered to pay more than $1 billion in fines and other penalties over its marketing of the opioid painkiller Opana ER.Read moreMICHAEL BRYANT / MCT